Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Net Cash Flow (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Net Cash Flow for 16 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 672.63% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 48.75% year-over-year, with the annual reading at $1.3 million for FY2025, 48.75% down from the prior year.
  • Net Cash Flow for Q4 2025 was $1.8 million at Creative Medical Technology Holdings, up from -$1.2 million in the prior quarter.
  • The five-year high for Net Cash Flow was $13.7 million in Q2 2022, with the low at -$8.6 million in Q4 2022.
  • Average Net Cash Flow over 5 years is $355505.7, with a median of -$218291.0 recorded in 2021.
  • Peak annual rise in Net Cash Flow hit 131533.57% in 2021, while the deepest fall reached 8817.06% in 2021.
  • Over 5 years, Net Cash Flow stood at $8.3 million in 2021, then plummeted by 203.63% to -$8.6 million in 2022, then skyrocketed by 87.97% to -$1.0 million in 2023, then surged by 69.23% to -$320036.0 in 2024, then skyrocketed by 672.63% to $1.8 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $1.8 million, -$1.2 million, and -$1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.